Vanda Pharmaceuticals, Inc VNDA Securities Lawsuit

- by

Company: Vanda Pharmaceuticals, Inc
Ticker Symbol: VNDA
Class Period: Dec-18-12 to Jun-18-13
Date Filed: Jun-26-13
Lead Plaintiff Deadline: Aug-25-13
Court: District of Columbia
Oklahoma City, OK: A securities class action lawsuit was filed in the United States District Court for the District of Columbia against Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA).

The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is December 18, 2012 through June 18, 2013.

Plaintiff seeks to recover damages on behalf of all Vanda Pharmaceuticals, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Vanda Pharmaceuticals, Inc VNDA Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Vanda Pharmaceuticals, Inc securities class action lawsuit. Please click the link below to submit your complaint for a free evaluation.

Maybe it's your stockbroker

Add Your Comment on This Issue

Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:
Request Legal Help